TriaGen Wealth Management LLC Invests $2.29 Million in CME Group Inc. $CME

Key Points

• TriaGen Wealth Management LLC acquired a new stake in CME Group, purchasing 8,626 shares for about $2.3 million, representing around 0.8% of its investment portfolio.
• Several analysts have raised their price targets for CME Group, with Oppenheimer increasing it to $303.00 and Morgan Stanley to $304.00, while the consensus rating currently stands at "Hold."
• CME Group recently announced a dividend of $1.25 per share, with a payout ratio of 48.40%, highlighting the company's commitment to returning value to shareholders.

TriaGen Wealth Management LLC bought a new position in shares of CME Group Inc. (NASDAQ:CME - Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 8,626 shares of the financial services provider's stock, valued at approximately $2,288,000. CME Group comprises 0.8% of TriaGen Wealth Management LLC's portfolio, making the stock its 29th biggest position.

Other institutional investors also recently bought and sold shares of the company. Heartland Bank & Trust Co purchased a new position in shares of CME Group during the first quarter valued at about $377,000. Catalyst Capital Advisors LLC boosted its stake in CME Group by 256.9% during the first quarter. Catalyst Capital Advisors LLC now owns 3,662 shares of the financial services provider's stock valued at $971,000 after buying an additional 2,636 shares during the last quarter. OMNI 360 Wealth Inc. purchased a new position in CME Group during the 1st quarter valued at approximately $367,000. Fulcrum Equity Management bought a new stake in CME Group in the 1st quarter worth approximately $258,000. Finally, AIA Group Ltd increased its stake in CME Group by 17.8% in the 1st quarter. AIA Group Ltd now owns 16,645 shares of the financial services provider's stock worth $4,416,000 after acquiring an additional 2,510 shares during the last quarter. 87.75% of the stock is owned by hedge funds and other institutional investors.

CME Group Trading Up 1.1%

CME Group stock traded up $3.12 during trading hours on Wednesday, hitting $274.61. The company had a trading volume of 1,736,586 shares, compared to its average volume of 2,337,134. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. The firm has a market cap of $98.96 billion, a P/E ratio of 26.58, a P/E/G ratio of 4.80 and a beta of 0.44. The company has a 50-day moving average price of $275.67 and a two-hundred day moving average price of $267.85. CME Group Inc. has a 1 year low of $206.44 and a 1 year high of $290.79.

CME Group (NASDAQ:CME - Get Free Report) last issued its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, topping analysts' consensus estimates of $2.91 by $0.05. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The business had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.68 billion. During the same period last year, the company posted $2.56 earnings per share. The company's quarterly revenue was up 10.4% compared to the same quarter last year. On average, sell-side analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th will be issued a $1.25 dividend. This represents a $5.00 annualized dividend and a dividend yield of 1.8%. The ex-dividend date is Tuesday, September 9th. CME Group's dividend payout ratio is currently 48.40%.

Insider Transactions at CME Group

In related news, Director Daniel G. Kaye sold 500 shares of the company's stock in a transaction dated Thursday, May 22nd. The shares were sold at an average price of $282.42, for a total value of $141,210.00. Following the completion of the sale, the director directly owned 3,668 shares of the company's stock, valued at $1,035,916.56. This represents a 12.00% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Charles P. Carey sold 500 shares of the stock in a transaction dated Tuesday, June 10th. The stock was sold at an average price of $265.35, for a total transaction of $132,675.00. Following the transaction, the director owned 4,900 shares in the company, valued at approximately $1,300,215. The trade was a 9.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.30% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on the company. Keefe, Bruyette & Woods increased their target price on CME Group from $265.00 to $273.00 and gave the company a "market perform" rating in a research report on Thursday, April 24th. Morgan Stanley increased their price target on shares of CME Group from $301.00 to $304.00 and gave the company an "overweight" rating in a report on Thursday, April 24th. Oppenheimer boosted their price objective on CME Group from $300.00 to $303.00 and gave the stock an "outperform" rating in a research note on Thursday, July 24th. Piper Sandler raised their price objective on CME Group from $283.00 to $296.00 and gave the company an "overweight" rating in a research note on Tuesday, July 15th. Finally, UBS Group reissued a "neutral" rating and set a $305.00 target price on shares of CME Group in a research report on Thursday, July 24th. Four analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have given a Sell rating to the company. According to MarketBeat, the company presently has an average rating of "Hold" and an average target price of $261.93.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.